Compounds and methods of targeting interleukin-34

The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or Tauopathy diseases. 本公开内容涉及IL-3...

Full description

Saved in:
Bibliographic Details
Main Authors SCOLA, ANDREW, DAVID, MINTHONG MILIND, WEST ERIC ANTHONY, LOO ALEXANDER, SIMS, JOHN, R., II, WALSH, RICHARD, E, CHEAD MICHAEL, FLEISCHER AMY S, RANNAN MANISH BABU, RAINES, SCOTT, E, OBUNGU VICTOR H, YE, MING
Format Patent
LanguageChinese
English
Published 09.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or Tauopathy diseases. 本公开内容涉及IL-34抗体、包含其的组合物以及使用所述抗体和或其组合物用于治疗诸如神经变性疾病的免疫介导的疾病的方法，例如阿尔茨海默病或Tau蛋白病变疾病。
AbstractList The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or Tauopathy diseases. 本公开内容涉及IL-34抗体、包含其的组合物以及使用所述抗体和或其组合物用于治疗诸如神经变性疾病的免疫介导的疾病的方法，例如阿尔茨海默病或Tau蛋白病变疾病。
Author RANNAN MANISH BABU
LOO ALEXANDER
SCOLA, ANDREW, DAVID
YE, MING
WEST ERIC ANTHONY
FLEISCHER AMY S
WALSH, RICHARD, E
CHEAD MICHAEL
SIMS, JOHN, R., II
OBUNGU VICTOR H
RAINES, SCOTT, E
MINTHONG MILIND
Author_xml – fullname: SCOLA, ANDREW, DAVID
– fullname: MINTHONG MILIND
– fullname: WEST ERIC ANTHONY
– fullname: LOO ALEXANDER
– fullname: SIMS, JOHN, R., II
– fullname: WALSH, RICHARD, E
– fullname: CHEAD MICHAEL
– fullname: FLEISCHER AMY S
– fullname: RANNAN MANISH BABU
– fullname: RAINES, SCOTT, E
– fullname: OBUNGU VICTOR H
– fullname: YE, MING
BookMark eNrjYmDJy89L5WQwdM7PLcgvzUspVkjMS1HITS3JyAey89MUShKL0lNLMvPSFTLzSlKLclJLszPzdI1NeBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJvLOfoaGFibmpmaGBozExagB7rS0v
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 靶向白细胞介素-34的化合物和方法
ExternalDocumentID CN118475610A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN118475610A3
IEDL.DBID EVB
IngestDate Fri Nov 01 05:50:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN118475610A3
Notes Application Number: CN20228086946
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240809&DB=EPODOC&CC=CN&NR=118475610A
ParticipantIDs epo_espacenet_CN118475610A
PublicationCentury 2000
PublicationDate 20240809
PublicationDateYYYYMMDD 2024-08-09
PublicationDate_xml – month: 08
  year: 2024
  text: 20240809
  day: 09
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies ELI LILLY AND COMPANY
RelatedCompanies_xml – name: ELI LILLY AND COMPANY
Score 3.693042
Snippet The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Compounds and methods of targeting interleukin-34
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240809&DB=EPODOC&locale=&CC=CN&NR=118475610A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsTQ0Bt1_Y6SbnJIMusIsyVI3KdnUUBfYOE8GVoBpxmZp4AWyfmYeoSZeEaYRTAxZsL0w4HNCy8GHIwJzVDIwv5eAy-sCxCCWC3htZbF-UiZQKN_eLcTWRQ3aOwad12VgqebiZOsa4O_i76zm7Gzr7KfmF2QLbEebmIPaCo7MDKzAZrQ5uNMW5gTalVKAXKW4CTKwBQBNyysRYmCqyhBm4HSG3bwmzMDhC53wBjKhea9YhMEQlHVBlyAVKwB7_wqQq5-LFfLTFCCruYF1kALo8IeinNTS7Mw8XWMTUQZFN9cQZw9doN3xcI_GO_shnGksxsCSl5-XKsGgYGyZZphqmpSUlJhoZJKcYphkYJwKOsfQLA3YdjNPsZBkkMJtjhQ-SWkGLlCggRe0WcowsJQUlabKAivZkiQ5cOgAADQcf_o
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsTQ0Bt1_Y6SbnJIMusIsyVI3KdnUUBfYOE8GVoBpxmZp4AWyfmYeoSZeEaYRTAxZsL0w4HNCy8GHIwJzVDIwv5eAy-sCxCCWC3htZbF-UiZQKN_eLcTWRQ3aOwad12VgqebiZOsa4O_i76zm7Gzr7KfmF2QLbEebmIPaCo7MDKzAJrYFuKsU5gTalVKAXKW4CTKwBQBNyysRYmCqyhBm4HSG3bwmzMDhC53wBjKhea9YhMEQlHVBlyAVKwB7_wqQq5-LFfLTFCCruYF1kALo8IeinNTS7Mw8XWMTUQZFN9cQZw9doN3xcI_GO_shnGksxsCSl5-XKsGgYGyZZphqmpSUlJhoZJKcYphkYJwKOsfQLA3YdjNPsZBkkMJtjhQ-SXkGTo8QX594H08_b2kGLlAAghe3WcowsJQUlabKAivckiQ5cEgBAFvMguo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compounds+and+methods+of+targeting+interleukin-34&rft.inventor=SCOLA%2C+ANDREW%2C+DAVID&rft.inventor=MINTHONG+MILIND&rft.inventor=WEST+ERIC+ANTHONY&rft.inventor=LOO+ALEXANDER&rft.inventor=SIMS%2C+JOHN%2C+R.%2C+II&rft.inventor=WALSH%2C+RICHARD%2C+E&rft.inventor=CHEAD+MICHAEL&rft.inventor=FLEISCHER+AMY+S&rft.inventor=RANNAN+MANISH+BABU&rft.inventor=RAINES%2C+SCOTT%2C+E&rft.inventor=OBUNGU+VICTOR+H&rft.inventor=YE%2C+MING&rft.date=2024-08-09&rft.externalDBID=A&rft.externalDocID=CN118475610A